Therapeutic Paradoxes – A Case Report of Bleomycin-induced Lung Injury
Bleomycin, a key chemotherapeutic for conditions such as germ cell tumors and Hodgkin’s lymphoma, often carries the risk of life-threatening pulmonary toxicity. In Hodgkin’s lymphoma, the incidence of bleomycin-induced lung injury (BILI) is around 10%, with fatal cases at 4%–5%. BILI typically prese...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer Medknow Publications
2026-01-01
|
| Collection: | Journal of Advanced Lung Health |
| Sujets: | |
| Accès en ligne: | https://journals.lww.com/10.4103/jalh.jalh_54_24 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|